Amoxicillin + Clavulanic Acid

Verify with FDA CVM →

263 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
263
Total Reports
31
Deaths Reported
1180.0%
Death Rate

Active Ingredients

AmoxicillinAmoxicillin + Clavulanic AcidClavulanic Acid

Administration Routes

UnknownOralAuricular (Otic)

Species Affected

Dog 152
Cat 107
Human 3
Unknown 1

Most Affected Breeds

Domestic Shorthair 73
Retriever - Labrador 15
Cat (unknown) 10
Shih Tzu 9
Domestic Longhair 9
Retriever - Golden 6
Spitz - German Pomeranian 6
Bulldog - French 6
Unknown 5
Pointing Dog - Hungarian Short-haired (Vizsla) 5

Most Reported Reactions

Vomiting 51
Lethargy (see also Central nervous system depression in Neurological) 39
Other abnormal test result NOS 38
Decreased appetite 36
Not eating 32
Diarrhoea 27
Weight loss 27
Death by euthanasia 26
Elevated alanine aminotransferase (ALT) 24
Behavioural disorder NOS 24
Leucocytosis NOS 23
Hyperglycaemia 23

Outcome Breakdown

Ongoing
99 (37.6%)
Outcome Unknown
87 (33.1%)
Recovered/Normal
45 (17.1%)
Euthanized
25 (9.5%)
Died
6 (2.3%)
Recovered with Sequela
1 (0.4%)

Data Summary

Metric Value
Total adverse event reports 263
Reports involving death 31
Case-fatality rate (reported events) 1180.0%
Distinct species in reports 4
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 3

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Amoxicillin + Clavulanic Acid Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 263 adverse event reports referencing Amoxicillin + Clavulanic Acid, including 31 reports in which the animal died — a 1180.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredients on file: Amoxicillin, Amoxicillin + Clavulanic Acid, Clavulanic Acid. Reported administration routes include Unknown, Oral, Auricular (Otic). These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Amoxicillin + Clavulanic Acid reports are Dog (152 reports), Cat (107 reports), Human (3 reports), with Dog accounting for the largest share. Within those species, Domestic Shorthair (73), Retriever - Labrador (15), Cat (unknown) (10) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Amoxicillin + Clavulanic Acid are Vomiting (51), Lethargy (see also Central nervous system depression in Neurological) (39), Other abnormal test result NOS (38), Decreased appetite (36). Of the 263 reports with a coded outcome, Ongoing is the leading category at 37.6%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Amoxicillin + Clavulanic Acid.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial